Cargando…
Developing Phytocompounds from Medicinal Plants as Immunomodulators
Imbalance or malfunction of the immune systems is associated with a range of chronic diseases including autoimmune diseases, allergies, cancers and others. Various innate and adaptive immune cells that are integrated in this complex networking system may represent promising targets for developing im...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7150268/ https://www.ncbi.nlm.nih.gov/pubmed/32300254 http://dx.doi.org/10.1016/B978-0-12-394591-4.00004-0 |
_version_ | 1783520991867043840 |
---|---|
author | Wen, Chih-Chun Chen, Hui-Ming Yang, Ning-Sun |
author_facet | Wen, Chih-Chun Chen, Hui-Ming Yang, Ning-Sun |
author_sort | Wen, Chih-Chun |
collection | PubMed |
description | Imbalance or malfunction of the immune systems is associated with a range of chronic diseases including autoimmune diseases, allergies, cancers and others. Various innate and adaptive immune cells that are integrated in this complex networking system may represent promising targets for developing immunotherapeutics for treating specific immune diseases. A spectrum of phytochemicals have been isolated, characterized and modified for development and use as prevention or treatment of human diseases. Many cytotoxic drugs and antibiotics have been developed from phytocompounds, but the application of traditional or new medicinal plants for use as immunomodulators in treating immune diseases is still relatively limited. In this review, a selected group of medicinal herbs, their derived crude or fractionated phytoextracts and the specific phytochemicals/phytocompounds isolated from them, as well as categorized phytocompound groups with specific chemical structures are discussed in terms of their immunomodulatory bioactivities. We also assess their potential for future development as immunomodulatory or inflammation-regulatory therapeutics or agents. New experimental approaches for evaluating the immunomodulatory activities of candidate phytomedicines are also discussed. |
format | Online Article Text |
id | pubmed-7150268 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71502682020-04-13 Developing Phytocompounds from Medicinal Plants as Immunomodulators Wen, Chih-Chun Chen, Hui-Ming Yang, Ning-Sun Adv Bot Res Article Imbalance or malfunction of the immune systems is associated with a range of chronic diseases including autoimmune diseases, allergies, cancers and others. Various innate and adaptive immune cells that are integrated in this complex networking system may represent promising targets for developing immunotherapeutics for treating specific immune diseases. A spectrum of phytochemicals have been isolated, characterized and modified for development and use as prevention or treatment of human diseases. Many cytotoxic drugs and antibiotics have been developed from phytocompounds, but the application of traditional or new medicinal plants for use as immunomodulators in treating immune diseases is still relatively limited. In this review, a selected group of medicinal herbs, their derived crude or fractionated phytoextracts and the specific phytochemicals/phytocompounds isolated from them, as well as categorized phytocompound groups with specific chemical structures are discussed in terms of their immunomodulatory bioactivities. We also assess their potential for future development as immunomodulatory or inflammation-regulatory therapeutics or agents. New experimental approaches for evaluating the immunomodulatory activities of candidate phytomedicines are also discussed. Elsevier Ltd. 2012 2012-06-19 /pmc/articles/PMC7150268/ /pubmed/32300254 http://dx.doi.org/10.1016/B978-0-12-394591-4.00004-0 Text en Copyright © 2012 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Wen, Chih-Chun Chen, Hui-Ming Yang, Ning-Sun Developing Phytocompounds from Medicinal Plants as Immunomodulators |
title | Developing Phytocompounds from Medicinal Plants as Immunomodulators |
title_full | Developing Phytocompounds from Medicinal Plants as Immunomodulators |
title_fullStr | Developing Phytocompounds from Medicinal Plants as Immunomodulators |
title_full_unstemmed | Developing Phytocompounds from Medicinal Plants as Immunomodulators |
title_short | Developing Phytocompounds from Medicinal Plants as Immunomodulators |
title_sort | developing phytocompounds from medicinal plants as immunomodulators |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7150268/ https://www.ncbi.nlm.nih.gov/pubmed/32300254 http://dx.doi.org/10.1016/B978-0-12-394591-4.00004-0 |
work_keys_str_mv | AT wenchihchun developingphytocompoundsfrommedicinalplantsasimmunomodulators AT chenhuiming developingphytocompoundsfrommedicinalplantsasimmunomodulators AT yangningsun developingphytocompoundsfrommedicinalplantsasimmunomodulators |